In this report, the United States Rosiglitazone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Rosiglitazone in these regions, from 2012 to 2022 (forecast). United States Rosiglitazone market competition by top manufacturers/players, with Rosiglitazone sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including SB Pharmco Teva Sandoz Hikma Pharms Dr Reddys Labs Inc Watson Labs Roxane Mylan Pharma On the basis of product, this report displays the... Research Beam Model: Research Beam Product ID: 1979857 3800 USD New
United States Rosiglitazone Market Report 2017
 
 

United States Rosiglitazone Market Report 2017

  • Category : Healthcare
  • Published On : August   2017
  • Pages : 97
  • Publisher : QYResearch
 
 
 
In this report, the United States Rosiglitazone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Rosiglitazone in these regions, from 2012 to 2022 (forecast).

United States Rosiglitazone market competition by top manufacturers/players, with Rosiglitazone sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
SB Pharmco
Teva
Sandoz
Hikma Pharms
Dr Reddys Labs Inc
Watson Labs
Roxane
Mylan Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
1 mg
2 mg
4 mg
8 mg
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Rosiglitazone for each application, including
Hospital
Pharmacy
Clinics

Table of Contents

United States Rosiglitazone Market Report 2017
1 Rosiglitazone Overview
1.1 Product Overview and Scope of Rosiglitazone
1.2 Classification of Rosiglitazone by Product Category
1.2.1 United States Rosiglitazone Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Rosiglitazone Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 1 mg
1.2.4 2 mg
1.2.5 4 mg
1.2.6 8 mg
1.3 United States Rosiglitazone Market by Application/End Users
1.3.1 United States Rosiglitazone Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinics
1.4 United States Rosiglitazone Market by Region
1.4.1 United States Rosiglitazone Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Rosiglitazone Status and Prospect (2012-2022)
1.4.3 Southwest Rosiglitazone Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Rosiglitazone Status and Prospect (2012-2022)
1.4.5 New England Rosiglitazone Status and Prospect (2012-2022)
1.4.6 The South Rosiglitazone Status and Prospect (2012-2022)
1.4.7 The Midwest Rosiglitazone Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Rosiglitazone (2012-2022)
1.5.1 United States Rosiglitazone Sales and Growth Rate (2012-2022)
1.5.2 United States Rosiglitazone Revenue and Growth Rate (2012-2022)

2 United States Rosiglitazone Market Competition by Players/Suppliers
2.1 United States Rosiglitazone Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Rosiglitazone Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Rosiglitazone Average Price by Players/Suppliers (2012-2017)
2.4 United States Rosiglitazone Market Competitive Situation and Trends
2.4.1 United States Rosiglitazone Market Concentration Rate
2.4.2 United States Rosiglitazone Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Rosiglitazone Manufacturing Base Distribution, Sales Area, Product Type

3 United States Rosiglitazone Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Rosiglitazone Sales and Market Share by Region (2012-2017)
3.2 United States Rosiglitazone Revenue and Market Share by Region (2012-2017)
3.3 United States Rosiglitazone Price by Region (2012-2017)

4 United States Rosiglitazone Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Rosiglitazone Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Rosiglitazone Revenue and Market Share by Type (2012-2017)
4.3 United States Rosiglitazone Price by Type (2012-2017)
4.4 United States Rosiglitazone Sales Growth Rate by Type (2012-2017)

5 United States Rosiglitazone Sales (Volume) by Application (2012-2017)
5.1 United States Rosiglitazone Sales and Market Share by Application (2012-2017)
5.2 United States Rosiglitazone Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Rosiglitazone Players/Suppliers Profiles and Sales Data
6.1 SB Pharmco
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Rosiglitazone Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 SB Pharmco Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Teva
6.2.2 Rosiglitazone Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Teva Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sandoz
6.3.2 Rosiglitazone Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sandoz Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Hikma Pharms
6.4.2 Rosiglitazone Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Hikma Pharms Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Dr Reddys Labs Inc
6.5.2 Rosiglitazone Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Dr Reddys Labs Inc Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Watson Labs
6.6.2 Rosiglitazone Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Watson Labs Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Roxane
6.7.2 Rosiglitazone Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Roxane Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Mylan Pharma
6.8.2 Rosiglitazone Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Mylan Pharma Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview

7 Rosiglitazone Manufacturing Cost Analysis
7.1 Rosiglitazone Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rosiglitazone

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Rosiglitazone Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rosiglitazone Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Rosiglitazone Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Rosiglitazone Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Rosiglitazone Sales Volume Forecast by Type (2017-2022)
11.3 United States Rosiglitazone Sales Volume Forecast by Application (2017-2022)
11.4 United States Rosiglitazone Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Rosiglitazone
Figure United States Rosiglitazone Market Size (K Units) by Type (2012-2022)
Figure United States Rosiglitazone Sales Volume Market Share by Type (Product Category) in 2016
Figure 1 mg Product Picture
Figure 2 mg Product Picture
Figure 4 mg Product Picture
Figure 8 mg Product Picture
Figure United States Rosiglitazone Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Rosiglitazone by Application in 2016
Figure Hospital Examples
Figure Pharmacy Examples
Figure Clinics Examples
Figure United States Rosiglitazone Market Size (Million USD) by Region (2012-2022)
Figure The West Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Rosiglitazone Sales (K Units) and Growth Rate (2012-2022)
Figure United States Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Rosiglitazone Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Rosiglitazone Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Rosiglitazone Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Rosiglitazone Sales Share by Players/Suppliers
Figure 2017 United States Rosiglitazone Sales Share by Players/Suppliers
Figure United States Rosiglitazone Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Rosiglitazone Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Rosiglitazone Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Rosiglitazone Revenue Share by Players/Suppliers
Figure 2017 United States Rosiglitazone Revenue Share by Players/Suppliers
Table United States Market Rosiglitazone Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Rosiglitazone Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Rosiglitazone Market Share of Top 3 Players/Suppliers
Figure United States Rosiglitazone Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Rosiglitazone Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Rosiglitazone Product Category
Table United States Rosiglitazone Sales (K Units) by Region (2012-2017)
Table United States Rosiglitazone Sales Share by Region (2012-2017)
Figure United States Rosiglitazone Sales Share by Region (2012-2017)
Figure United States Rosiglitazone Sales Market Share by Region in 2016
Table United States Rosiglitazone Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Rosiglitazone Revenue Share by Region (2012-2017)
Figure United States Rosiglitazone Revenue Market Share by Region (2012-2017)
Figure United States Rosiglitazone Revenue Market Share by Region in 2016
Table United States Rosiglitazone Price (USD/Unit) by Region (2012-2017)
Table United States Rosiglitazone Sales (K Units) by Type (2012-2017)
Table United States Rosiglitazone Sales Share by Type (2012-2017)
Figure United States Rosiglitazone Sales Share by Type (2012-2017)
Figure United States Rosiglitazone Sales Market Share by Type in 2016
Table United States Rosiglitazone Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Rosiglitazone Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Rosiglitazone by Type (2012-2017)
Figure Revenue Market Share of Rosiglitazone by Type in 2016
Table United States Rosiglitazone Price (USD/Unit) by Types (2012-2017)
Figure United States Rosiglitazone Sales Growth Rate by Type (2012-2017)
Table United States Rosiglitazone Sales (K Units) by Application (2012-2017)
Table United States Rosiglitazone Sales Market Share by Application (2012-2017)
Figure United States Rosiglitazone Sales Market Share by Application (2012-2017)
Figure United States Rosiglitazone Sales Market Share by Application in 2016
Table United States Rosiglitazone Sales Growth Rate by Application (2012-2017)
Figure United States Rosiglitazone Sales Growth Rate by Application (2012-2017)
Table SB Pharmco Basic Information List
Table SB Pharmco Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure SB Pharmco Rosiglitazone Sales Growth Rate (2012-2017)
Figure SB Pharmco Rosiglitazone Sales Market Share in United States (2012-2017)
Figure SB Pharmco Rosiglitazone Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Rosiglitazone Sales Growth Rate (2012-2017)
Figure Teva Rosiglitazone Sales Market Share in United States (2012-2017)
Figure Teva Rosiglitazone Revenue Market Share in United States (2012-2017)
Table Sandoz Basic Information List
Table Sandoz Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sandoz Rosiglitazone Sales Growth Rate (2012-2017)
Figure Sandoz Rosiglitazone Sales Market Share in United States (2012-2017)
Figure Sandoz Rosiglitazone Revenue Market Share in United States (2012-2017)
Table Hikma Pharms Basic Information List
Table Hikma Pharms Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hikma Pharms Rosiglitazone Sales Growth Rate (2012-2017)
Figure Hikma Pharms Rosiglitazone Sales Market Share in United States (2012-2017)
Figure Hikma Pharms Rosiglitazone Revenue Market Share in United States (2012-2017)
Table Dr Reddys Labs Inc Basic Information List
Table Dr Reddys Labs Inc Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr Reddys Labs Inc Rosiglitazone Sales Growth Rate (2012-2017)
Figure Dr Reddys Labs Inc Rosiglitazone Sales Market Share in United States (2012-2017)
Figure Dr Reddys Labs Inc Rosiglitazone Revenue Market Share in United States (2012-2017)
Table Watson Labs Basic Information List
Table Watson Labs Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Watson Labs Rosiglitazone Sales Growth Rate (2012-2017)
Figure Watson Labs Rosiglitazone Sales Market Share in United States (2012-2017)
Figure Watson Labs Rosiglitazone Revenue Market Share in United States (2012-2017)
Table Roxane Basic Information List
Table Roxane Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roxane Rosiglitazone Sales Growth Rate (2012-2017)
Figure Roxane Rosiglitazone Sales Market Share in United States (2012-2017)
Figure Roxane Rosiglitazone Revenue Market Share in United States (2012-2017)
Table Mylan Pharma Basic Information List
Table Mylan Pharma Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan Pharma Rosiglitazone Sales Growth Rate (2012-2017)
Figure Mylan Pharma Rosiglitazone Sales Market Share in United States (2012-2017)
Figure Mylan Pharma Rosiglitazone Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rosiglitazone
Figure Manufacturing Process Analysis of Rosiglitazone
Figure Rosiglitazone Industrial Chain Analysis
Table Raw Materials Sources of Rosiglitazone Major Players/Suppliers in 2016
Table Major Buyers of Rosiglitazone
Table Distributors/Traders List
Figure United States Rosiglitazone Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Rosiglitazone Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Rosiglitazone Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Rosiglitazone Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Rosiglitazone Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Rosiglitazone Sales Volume (K Units) Forecast by Type in 2022
Table United States Rosiglitazone Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Rosiglitazone Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Rosiglitazone Sales Volume (K Units) Forecast by Application in 2022
Table United States Rosiglitazone Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Rosiglitazone Sales Volume Share Forecast by Region (2017-2022)
Figure United States Rosiglitazone Sales Volume Share Forecast by Region (2017-2022)
Figure United States Rosiglitazone Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

REQUEST SAMPLE    ASK FOR DISCOUNT